{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:51:54Z","timestamp":1791492714683,"version":"4.3.4"},"reference-count":220,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019446","name":"Medical and Health Science and Technology Development Project of Shandong Province","doi-asserted-by":"publisher","award":["202402070257"],"award-info":[{"award-number":["202402070257"]}],"id":[{"id":"10.13039\/501100019446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH501"],"award-info":[{"award-number":["ZR2023QH501"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.autrev.2026.104192","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:50:28Z","timestamp":1790981428000},"page":"104192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbiota and systemic sclerosis: Mechanistic insights and microbial therapies"],"prefix":"10.1016","author":[{"given":"Qi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.autrev.2026.104192_bb0005","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41584-022-00864-7","article-title":"Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis","volume":"18","author":"Fang","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"10373","key":"10.1016\/j.autrev.2026.104192_bb0010","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"issue":"10103","key":"10.1016\/j.autrev.2026.104192_bb0015","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb0020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12016-021-08889-8","article-title":"Current concepts on the pathogenesis of systemic sclerosis","volume":"64","author":"Truchetet","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104192_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2026.103988","article-title":"Gastrointestinal histology of systemic sclerosis: a systematic review","volume":"25","author":"Strother","year":"2026","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.autrev.2026.104192_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103342","article-title":"External and internal exposome as triggers of biological signalling in systemic sclerosis - a narrative synthesis","volume":"150","author":"Janssen","year":"2025","journal-title":"J Autoimmun"},{"issue":"9","key":"10.1016\/j.autrev.2026.104192_bb0040","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.autrev.2026.104192_bb0045","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/1756-185X.14333","article-title":"Rituximab on lung, skin, and joint involvement in patients with systemic sclerosis: a case series study and review of the literature","volume":"25","author":"Yarkan Tu\u011fsal","year":"2022","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/art.41933","article-title":"Systemic sclerosis-associated interstitial lung disease: how to incorporate two Food and Drug Administration-approved therapies in clinical practice","volume":"74","author":"Khanna","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"24","key":"10.1016\/j.autrev.2026.104192_bb0055","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.autrev.2026.104192_bb0060","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2468-1253(24)00390-X","article-title":"The intestinal barrier: a pivotal role in health, inflammation, and cancer","volume":"10","author":"Neurath","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104192_bb0065","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0070","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41579-024-01048-8","article-title":"The gut-airway microbiome axis in health and respiratory diseases","volume":"22","author":"\u00d6z\u00e7am","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.autrev.2026.104192_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104055","article-title":"Gut dysbiosis in rheumatic diseases: a systematic review and meta-analysis of 92 observational studies","volume":"80","author":"Wang","year":"2022","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.autrev.2026.104192_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103654","article-title":"Exploring the role of gut microbiome in autoimmune diseases: a comprehensive review","volume":"23","author":"Wang","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104192_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1215039","article-title":"Metabolic fingerprinting of systemic sclerosis: a systematic review","volume":"10","author":"Morales-Gonz\u00e1lez","year":"2023","journal-title":"Front Mol Biosci"},{"issue":"6","key":"10.1016\/j.autrev.2026.104192_bb0090","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/art.39572","article-title":"Association of Systemic Sclerosis with a unique colonic microbial consortium","volume":"68","author":"Volkmann","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"Suppl. 125","key":"10.1016\/j.autrev.2026.104192_bb0095","first-page":"73","article-title":"Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status","volume":"38","author":"Natalello","year":"2020","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gande.2025.12.001","article-title":"A systematic review on gut microbiome and systemic sclerosis: current evidence and future directions","volume":"4","author":"Pingili","year":"2026","journal-title":"Gastroenterology & Endoscopy"},{"issue":"2","key":"10.1016\/j.autrev.2026.104192_bb0105","doi-asserted-by":"crossref","DOI":"10.1097\/RHU.0000000000001748","article-title":"Dysbiosis and gut microbiota modulation in systemic sclerosis","volume":"28","author":"Lemos","year":"2022","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13073-021-00853-7","article-title":"Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis","volume":"13","author":"Plichta","year":"2021","journal-title":"Genome Med"},{"issue":"6","key":"10.1016\/j.autrev.2026.104192_bb0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/BOR.0000000000001048","article-title":"Understanding the gastrointestinal microbiome in systemic sclerosis: methodological advancements and emerging research","volume":"36","author":"Haussmann","year":"2024","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0120","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0125","doi-asserted-by":"crossref","DOI":"10.1007\/s44466-026-00031-7","article-title":"Gut microbial metabolites and immune-related diseases","volume":"2","author":"Guo","year":"2026","journal-title":"Immun Inflamm"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2017-000134","article-title":"Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts","volume":"4","author":"Volkmann","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104192_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.647201","article-title":"Gut microbiota aberration in patients of systemic sclerosis and bleomycin-induced mice model","volume":"11","author":"Tang","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104192_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052765","article-title":"Butyrate improves skin\/lung fibrosis and intestinal Dysbiosis in bleomycin-induced mouse models","volume":"22","author":"Park","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.autrev.2026.104192_bb0145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/acr2.11387","article-title":"Disease features and gastrointestinal microbial composition in patients with systemic sclerosis from two independent cohorts","volume":"4","author":"Andr\u00e9asson","year":"2022","journal-title":"ACR Open Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0150","first-page":"1578","article-title":"Gut microbiome profiling in systemic sclerosis: a metagenomic approach","volume":"41","author":"Tan","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb0155","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/23971983211032808","article-title":"Fecal microbiome differs between patients with systemic sclerosis with and without small intestinal bacterial overgrowth","volume":"6","author":"Levin","year":"2021","journal-title":"J Scleroderma Relat Disord"},{"issue":"4","key":"10.1016\/j.autrev.2026.104192_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004647","article-title":"Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile","volume":"10","author":"Bellando-Randone","year":"2024","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0165","doi-asserted-by":"crossref","first-page":"14874","DOI":"10.1038\/s41598-017-14889-6","article-title":"Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement","volume":"7","author":"Patrone","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/nyas.13736","article-title":"Microbial and metabolic multi-omic correlations in systemic sclerosis patients","volume":"1421","author":"Bellocchi","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2026.104192_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152185","article-title":"Gastrointestinal tract involvement in systemic sclerosis: the roles of diet and the microbiome","volume":"60","author":"Nguyen","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0180","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13075-016-1182-z","article-title":"Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease","volume":"18","author":"Andr\u00e9asson","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.autrev.2026.104192_bb0185","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14309\/ajg.0000000000000501","article-title":"ACG clinical guideline: small intestinal bacterial overgrowth","volume":"115","author":"Pimentel","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104192_bb0190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5056\/jnm22168","article-title":"Small intestinal bacterial overgrowth complicating gastrointestinal manifestations of systemic sclerosis: a systematic review and Meta-analysis","volume":"29","author":"Shah","year":"2023","journal-title":"J Neurogastroenterol Motil"},{"issue":"7","key":"10.1016\/j.autrev.2026.104192_bb0195","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1007\/s12010-025-05249-6","article-title":"Untargeted metabolomics revealed Metabolomic profile in patients with primary systemic sclerosis","volume":"197","author":"Tang","year":"2025","journal-title":"Appl Biochem Biotechnol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104192_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2022.08.009","article-title":"Human gut microbiota stimulate defined innate immune responses that vary from phylum to strain","volume":"30","author":"Spindler","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.autrev.2026.104192_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/nu18071084","article-title":"Firmicutes\/Bacteroidetes ratio as an insufficient Indicator of metabolic status in Mexican Young adults","volume":"18","author":"Nez-Castro","year":"2026","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.autrev.2026.104192_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051474","article-title":"The Firmicutes\/Bacteroidetes ratio: a relevant marker of gut Dysbiosis in obese patients?","volume":"12","author":"Magne","year":"2020","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.autrev.2026.104192_bb0220","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01576-24","article-title":"Unraveling the interplay between mesenchymal stem cells, gut microbiota, and systemic sclerosis: therapeutic implications","volume":"13","author":"Zhang","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.autrev.2026.104192_bb0235","doi-asserted-by":"crossref","first-page":"110","DOI":"10.33590\/emj\/20-00043","article-title":"Longitudinal characterisation of the gastrointestinal tract microbiome in systemic sclerosis","volume":"7","author":"Volkmann","year":"2020","journal-title":"Eur Med J (Chelmsf)"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0225","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/rheumatology\/kead208","article-title":"The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis","volume":"63","author":"Russo","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0215","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nbt.3893","article-title":"Minimum information about a single amplified genome (MISAG) and a metagenome-assembled genome (MIMAG) of bacteria and archaea","volume":"35","author":"Bowers","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104192_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9061298","article-title":"Oral Lactobacillus species in systemic sclerosis","volume":"9","author":"Melchiorre","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0240","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2407526","article-title":"Autoantibodies in systemic sclerosis overlap syndrome and their correlation with organ damage and survival","volume":"56","author":"Wang","year":"2024","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102713","article-title":"The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: systematic review and meta-analysis","volume":"20","author":"Rubio-Rivas","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0250","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2393270","article-title":"The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease","volume":"16","author":"Hays","year":"2024","journal-title":"Gut Microbes."},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0255","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13075-023-03118-3","article-title":"Faecalibacterium prausnitzii alleviates inflammatory arthritis and regulates IL-17 production, short chain fatty acids, and the intestinal microbial flora in experimental mouse model for rheumatoid arthritis","volume":"25","author":"Moon","year":"2023","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb0260","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semarthrit.2019.05.006","article-title":"A double-blind randomized placebo-controlled trial of probiotics in systemic sclerosis associated gastrointestinal disease","volume":"49","author":"Low","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2026.104192_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2024.04.020","article-title":"Enterococcus-derived tyramine hijacks \u03b1(2A)-adrenergic receptor in intestinal stem cells to exacerbate colitis","volume":"32","author":"Li","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"12","key":"10.1016\/j.autrev.2026.104192_bb0270","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1093\/rheumatology\/keab262","article-title":"A review and roadmap of the skin, lung and gut microbiota in systemic sclerosis","volume":"60","author":"Teaw","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.autrev.2026.104192_bb0275","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb0280","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/acr.25623","article-title":"International investigation of the gut-lung axis in systemic sclerosis-interstitial lung disease","volume":"78","author":"Andr\u00e9asson","year":"2026","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0285","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00296-024-05783-2","article-title":"Association of nutritional status indices with gastrointestinal symptoms in systemic sclerosis: a cross-sectional study","volume":"45","author":"\u00d6z","year":"2025","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.autrev.2026.104192_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.10.029","article-title":"US immigration westernizes the human gut microbiome","volume":"175","author":"Vangay","year":"2018","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.autrev.2026.104192_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2023.05.024","article-title":"Enterosignatures define common bacterial guilds in the human gut microbiome","volume":"31","author":"Frioux","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.autrev.2026.104192_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1610360","article-title":"Ultra-processed food intake is associated with increased gastrointestinal tract symptoms and alterations in gut microbiota in patients with systemic sclerosis","volume":"16","author":"Lee","year":"2025","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104192_bb0305","first-page":"489","article-title":"Antibiotics in early life: dysbiosis and the damage done","volume":"42","author":"Neuman","year":"2018","journal-title":"FEMS Microbiol Rev"},{"issue":"11","key":"10.1016\/j.autrev.2026.104192_bb0310","doi-asserted-by":"crossref","first-page":"16140","DOI":"10.1038\/nmicrobiol.2016.140","article-title":"Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice","volume":"1","author":"Livanos","year":"2016","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0315","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ismej.2007.3","article-title":"Long-term ecological impacts of antibiotic administration on the human intestinal microbiota","volume":"1","author":"Jernberg","year":"2007","journal-title":"ISME J"},{"issue":"11","key":"10.1016\/j.autrev.2026.104192_bb0320","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.jid.2017.06.019","article-title":"Early-life antibiotic exposure causes intestinal Dysbiosis and exacerbates skin and lung pathology in experimental systemic sclerosis","volume":"137","author":"Mehta","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.autrev.2026.104192_bb0325","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.jid.2017.08.017","article-title":"Early-life gut Dysbiosis: a driver of later-life fibrosis?","volume":"137","author":"Ho","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"8076","key":"10.1016\/j.autrev.2026.104192_bb0330","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41586-025-09217-2","article-title":"Non-antibiotics disrupt colonization resistance against enteropathogens","volume":"644","author":"Grie\u00dfhammer","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104192_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.736036","article-title":"Proton pump inhibitors increase the risk of autoimmune diseases: a Nationwide cohort study","volume":"12","author":"Lin","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0340","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12866-023-02895-w","article-title":"Meta-analysis of the effects of proton pump inhibitors on the human gut microbiota","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Microbiol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104192_bb0350","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nbt.3935","article-title":"Shotgun metagenomics, from sampling to analysis","volume":"35","author":"Quince","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104192_bb0355","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03512-23","article-title":"Optimal 16S rRNA gene amplicon sequencing analysis for oral microbiota to avoid the potential bias introduced by trimming length, primer, and database","volume":"12","author":"Nagai","year":"2024","journal-title":"Microbiol Spectr."},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0360","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41467-022-28034-z","article-title":"Microbiome differential abundance methods produce different results across 38 datasets","volume":"13","author":"Nearing","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.autrev.2026.104192_bb0365","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.01358-24","article-title":"Comparison of different microbiome analysis pipelines to validate their reproducibility of gastric mucosal microbiome composition","volume":"10","author":"Lehr","year":"2025","journal-title":"mSystems"},{"key":"10.1016\/j.autrev.2026.104192_bb0370","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/annrheumdis-2024-eular.5006","article-title":"POS0044\u00a0DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION","volume":"83","author":"Russo","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104192_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1427195","article-title":"The effect of gut microbiome and plasma metabolome on systemic sclerosis: a bidirectional two-sample Mendelian randomization study","volume":"15","author":"Xie","year":"2024","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0380","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-024-01466-1","article-title":"Serum markers of microbial translocation and intestinal damage in assessment of gastrointestinal tract involvement in systemic sclerosis","volume":"24","author":"Pellicano","year":"2024","journal-title":"Clin Exp Med"},{"issue":"12","key":"10.1016\/j.autrev.2026.104192_bb0385","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.it.2023.10.004","article-title":"Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis","volume":"44","author":"Rodr\u00edguez-Morales","year":"2023","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb0390","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.immuni.2020.02.016","article-title":"Innate lymphoid cell-epithelial cell modules sustain intestinal homeostasis","volume":"52","author":"Diefenbach","year":"2020","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.autrev.2026.104192_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103637","article-title":"The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: a systematic review","volume":"23","author":"Campitiello","year":"2024","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2026.104192_bb0400","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.41243","article-title":"Profibrotic activation of human macrophages in systemic sclerosis","volume":"72","author":"Bhandari","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104192_bb0405","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/rheumatology\/keac410","article-title":"Macrophages as determinants and regulators of fibrosis in systemic sclerosis","volume":"62","author":"Al-Adwi","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb0410","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/annrheumdis-2015-207388","article-title":"Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis","volume":"75","author":"Wohlfahrt","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2026.104192_bb0415","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/annrheumdis-2020-219748","article-title":"TGF\u03b2 promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis","volume":"80","author":"Laurent","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0420","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s41598-025-85895-2","article-title":"Inhibition of skin fibrosis via regulation of Th17\/Treg imbalance in systemic sclerosis","volume":"15","author":"Sekiguchi","year":"2025","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.autrev.2026.104192_bb0425","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.7150\/thno.43716","article-title":"Parthenolide ameliorates colon inflammation through regulating Treg\/Th17 balance in a gut microbiota-dependent manner","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.autrev.2026.104192_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156534","article-title":"Th17\/IL-17A axis is critical for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc): SSc patients with high levels of serum IL-17A exhibit reduced lung functions and increased prevalence of PAH","volume":"176","author":"Seki","year":"2024","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0435","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-018-0758-9","article-title":"Update on the gastrointestinal microbiome in systemic sclerosis","volume":"20","author":"Bellocchi","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.autrev.2026.104192_bb0440","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/art.41927","article-title":"Defective early B cell tolerance checkpoints in patients with systemic sclerosis allow the production of self antigen-specific clones","volume":"74","author":"Glauzy","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104192_bb0445","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.autrev.2011.04.013","article-title":"B cells in systemic sclerosis: a possible target for therapy","volume":"10","author":"Bosello","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2026.104192_bb0450","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/art.39437","article-title":"Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis","volume":"68","author":"Mavropoulos","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb0455","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/art.40390","article-title":"Association of Defective Regulation of autoreactive Interleukin-6-producing transitional B lymphocytes with disease in patients with systemic sclerosis","volume":"70","author":"Taher","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104192_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123402","article-title":"Molecular basis of accelerated aging with immune dysfunction-mediated inflammation (Inflamm-aging) in patients with systemic sclerosis","volume":"10","author":"Shen","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.autrev.2026.104192_bb0465","doi-asserted-by":"crossref","first-page":"H303","DOI":"10.1152\/ajpheart.00545.2023","article-title":"Fibroblasts and immune cells: at the crossroad of organ inflammation and fibrosis","volume":"326","author":"Smolgovsky","year":"2024","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11082110","article-title":"Disturbed antioxidant capacity in patients with systemic sclerosis associates with lung and gastrointestinal symptoms","volume":"11","author":"Brezovec","year":"2023","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.autrev.2026.104192_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350631","article-title":"Epithelial-immune cell crosstalk for intestinal barrier homeostasis","volume":"54","author":"Yao","year":"2024","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104192_bb0480","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S2468-1253(21)00431-3","article-title":"The role of mucins in gastrointestinal barrier function during health and disease","volume":"7","author":"Breugelmans","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0485","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.molmed.2026.01.002","article-title":"Advances in blood-based biomarkers of gut barrier integrity","volume":"32","author":"Wouda","year":"2026","journal-title":"Trends Mol Med"},{"issue":"17","key":"10.1016\/j.autrev.2026.104192_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176402","article-title":"Gut microbiota and intestinal trans-epithelial permeability","volume":"21","author":"Allam-Ndoul","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.autrev.2026.104192_bb0495","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41564-021-01050-3","article-title":"Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity","volume":"7","author":"Mills","year":"2022","journal-title":"Nat Microbiol"},{"issue":"7","key":"10.1016\/j.autrev.2026.104192_bb0500","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/IAI.00425-15","article-title":"Enterococcus faecalis gelatinase mediates intestinal permeability via protease-activated receptor 2","volume":"83","author":"Maharshak","year":"2015","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.autrev.2026.104192_bb0505","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1007\/s10620-012-2259-4","article-title":"Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription","volume":"57","author":"Wang","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.autrev.2026.104192_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13040678","article-title":"The clinical significance of serum biomarkers of the intestinal barrier in systemic sclerosis: a cross-sectional study","volume":"13","author":"Stec","year":"2023","journal-title":"J Pers Med"},{"issue":"668","key":"10.1016\/j.autrev.2026.104192_bb0515","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn5166","article-title":"Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of Subdoligranulum","volume":"14","author":"Chriswell","year":"2022","journal-title":"Sci Transl Med"},{"issue":"376","key":"10.1016\/j.autrev.2026.104192_bb0520","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf9655","article-title":"IgA-coated E. Coli enriched in Crohn\u2019s disease spondyloarthritis promote T(H)17-dependent inflammation","volume":"9","author":"Viladomiu","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2026.104192_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101806","article-title":"Microbiota-gut-brain axis in health and disease: is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?","volume":"191","author":"Pellegrini","year":"2020","journal-title":"Prog Neurobiol"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0530","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104192_bb0535","first-page":"1028","article-title":"The gut-liver axis: how the gut promotes liver disease","volume":"63","author":"Demir","year":"2022","journal-title":"Inn Med (Heidelb)"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0540","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2523815","article-title":"Microbiota-dependent metabolites - new engine for T cell warriors","volume":"17","author":"Tang","year":"2025","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10030607","article-title":"Plasma Metabolomic profiling reveals four possibly disrupted mechanisms in systemic sclerosis","volume":"10","author":"B\u00f6gl","year":"2022","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.autrev.2026.104192_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2026.104084","article-title":"Metabolic signatures in systemic autoimmune diseases: a state-of-the-art overview of systemic lupus erythematosus, primary Sj\u00f6gren\u2019s syndrome, and systemic sclerosis","volume":"25","author":"J\u0119dreas","year":"2026","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb0555","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.230014","article-title":"Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections","volume":"13","author":"Ney","year":"2023","journal-title":"Open Biol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0560","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s40001-025-03666-1","article-title":"Differential regulatory mechanisms of gut-derived SCFAs (acetate, propionate, butyrate) on the pulmonary TLR2 signaling pathway and their roles in the inflammatory balance of bacterial pneumonia","volume":"31","author":"Chen","year":"2026","journal-title":"Eur J Med Res"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0565","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1152\/physrev.00041.2018","article-title":"Free fatty acid receptors in health and disease","volume":"100","author":"Kimura","year":"2020","journal-title":"Physiol Rev"},{"issue":"9","key":"10.1016\/j.autrev.2026.104192_bb0570","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","article-title":"Histone post-translational modifications - cause and consequence of genome function","volume":"23","author":"Mill\u00e1n-Zambrano","year":"2022","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0575","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5687","article-title":"Microbial short chain fatty acids: effective histone deacetylase inhibitors in immune regulation (review)","volume":"57","author":"Wang","year":"2026","journal-title":"Int J Mol Med"},{"issue":"5","key":"10.1016\/j.autrev.2026.104192_bb0580","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41551-024-01190-x","article-title":"A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice","volume":"8","author":"Cao","year":"2024","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.autrev.2026.104192_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102913","article-title":"Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cells","volume":"58","author":"Takahashi","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0590","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-026-08264-1","article-title":"Microbiota-derived butyrate inhibits colonic epithelial pyroptosis and mitigates DSS-induced colitis via interacting with aryl hydrocarbon receptor","volume":"24","author":"Zou","year":"2026","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0595","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-025-02263-2","article-title":"Microbiota-derived butyrate alleviates asthma via inhibiting Tfh13-mediated IgE production","volume":"10","author":"Yu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"7480","key":"10.1016\/j.autrev.2026.104192_bb0600","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.autrev.2026.104192_bb0605","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/ibd\/izz046","article-title":"Microbiota metabolite butyrate differentially regulates Th1 and Th17 cells\u2019 differentiation and function in induction of colitis","volume":"25","author":"Chen","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.autrev.2026.104192_bb0610","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1111\/ajt.16522","article-title":"Microbiota and immunoregulation: a focus on regulatory B lymphocytes and transplantation","volume":"21","author":"Pacaud","year":"2021","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.autrev.2026.104192_bb0615","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3920\/BM2020.0057","article-title":"Short chain fatty acids in human gut and metabolic health","volume":"11","author":"Blaak","year":"2020","journal-title":"Benef Microbes"},{"issue":"5","key":"10.1016\/j.autrev.2026.104192_bb0620","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","article-title":"Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function","volume":"17","author":"Kelly","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.autrev.2026.104192_bb0625","doi-asserted-by":"crossref","DOI":"10.4110\/in.2024.24.e41","article-title":"Bifidobacterium longum RAPO attenuates dermal and pulmonary fibrosis in a mouse model of systemic sclerosis through macrophage modulation and growth of short-chain fatty acid producers","volume":"24","author":"Park","year":"2024","journal-title":"Immune Netw"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0630","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2026.104192_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.917966","article-title":"Associations of microbial and indoleamine-2,3-dioxygenase-derived tryptophan metabolites with immune activation in healthy adults","volume":"13","author":"Riazati","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112135","article-title":"Dietary tryptophan deficiency promotes gut ROR\u03b3t(+) Treg cells at the expense of Gata3(+) Treg cells and alters commensal microbiota metabolism","volume":"42","author":"Rankin","year":"2023","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.autrev.2026.104192_bb0645","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2023.04.006","article-title":"Modulation of T cells by tryptophan metabolites in the kynurenine pathway","volume":"44","author":"Stone","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.autrev.2026.104192_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103734","article-title":"Kynurenine induces T cell fat catabolism and has limited suppressive effects in vivo","volume":"74","author":"Siska","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.autrev.2026.104192_bb0655","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jare.2024.06.017","article-title":"Kynurenine acts as a signaling molecule to attenuate pulmonary fibrosis by enhancing the AHR-PTEN axis","volume":"71","author":"Wang","year":"2025","journal-title":"J Adv Res"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0660","doi-asserted-by":"crossref","DOI":"10.1093\/ismejo\/wrae166","article-title":"Gut microbiota dysbiosis deteriorates immunoregulatory effects of tryptophan via colonic indole and LBP\/HTR2B-mediated macrophage function","volume":"18","author":"Jiang","year":"2024","journal-title":"ISME J"},{"key":"10.1016\/j.autrev.2026.104192_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2025.128211","article-title":"The relationship between tryptophan metabolism and gut microbiota: interaction mechanism and potential effects in infection treatment","volume":"298","author":"Pei","year":"2025","journal-title":"Microbiol Res"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0670","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s10020-024-00895-8","article-title":"Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis","volume":"30","author":"Jang","year":"2024","journal-title":"Mol Med"},{"issue":"19","key":"10.1016\/j.autrev.2026.104192_bb0675","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13195984","article-title":"Elevated circulating levels of gut microbe-derived trimethylamine N-oxide are associated with systemic sclerosis","volume":"13","author":"Ho","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2026.104192_bb0680","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2147\/JIR.S409489","article-title":"The gut microbial metabolite trimethylamine N-oxide is linked to specific complications of systemic sclerosis","volume":"16","author":"Stec","year":"2023","journal-title":"J Inflamm Res"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0685","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1136\/gutjnl-2018-317155","article-title":"Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free mice","volume":"68","author":"Wu","year":"2019","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.autrev.2026.104192_bb0690","article-title":"Trimethylamine N-oxide (TMAO) acts as inhibitor of endothelial nitric oxide synthase (eNOS) and hampers NO production and acetylcholine-mediated vasorelaxation in rat aortas","volume":"14","author":"Martelli","year":"2025","journal-title":"Antioxidants (Basel)."},{"issue":"7","key":"10.1016\/j.autrev.2026.104192_bb0695","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1007\/s00204-026-04368-1","article-title":"Trimethylamine N-oxide (TMAO) disrupts endothelial junction integrity through VE-cadherin Tyr658 phosphorylation in vitro","volume":"100","author":"Amaral Bueno Azevedo","year":"2026","journal-title":"Arch Toxicol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0700","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2026.2657048","article-title":"Alteration of gut microbiota contributes to peritoneal fibrosis through increased production of trimethylamine N-oxide","volume":"18","author":"Xie","year":"2026","journal-title":"Gut Microbes."},{"issue":"7","key":"10.1016\/j.autrev.2026.104192_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104669","article-title":"Gut microbe-derived metabolite trimethylamine N-oxide activates PERK to drive fibrogenic mesenchymal differentiation","volume":"25","author":"Kim","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.autrev.2026.104192_bb0710","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1475528","article-title":"Gut microbiome and metabolomics in systemic sclerosis: feature, link and mechanisms","volume":"15","author":"Yao","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104192_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105516","article-title":"Human microbiome-derived peptide affects the development of experimental autoimmune encephalomyelitis via molecular mimicry","volume":"111","author":"Ma","year":"2025","journal-title":"EBioMedicine"},{"issue":"28","key":"10.1016\/j.autrev.2026.104192_bb0720","article-title":"A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes","volume":"120","author":"Correction to Supporting Information for Girdhar","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2019.05.003","article-title":"Pathogenic autoreactive T and B cells cross-react with Mimotopes expressed by a common human gut commensal to trigger autoimmunity","volume":"26","author":"Ruff","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"434","key":"10.1016\/j.autrev.2026.104192_bb0730","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan2306","article-title":"Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus","volume":"10","author":"Greiling","year":"2018","journal-title":"Sci Transl Med"},{"issue":"740","key":"10.1016\/j.autrev.2026.104192_bb0735","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adl6149","article-title":"The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis","volume":"16","author":"Gleeson","year":"2024","journal-title":"Sci Transl Med"},{"issue":"369","key":"10.1016\/j.autrev.2026.104192_bb0740","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaj1921","article-title":"Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis","volume":"8","author":"Konig","year":"2016","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0745","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.autrev.2008.07.022","article-title":"Systemic sclerosis and infections","volume":"8","author":"Randone","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0750","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1073\/pnas.1906593116","article-title":"HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry","volume":"117","author":"Gourh","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0755","doi-asserted-by":"crossref","first-page":"50","DOI":"10.31138\/mjr.31.1.50","article-title":"A bioinformatics analysis reveals novel pathogens as molecular mimicry triggers of systemic sclerosis","volume":"31","author":"Gkoutzourelas","year":"2020","journal-title":"Mediterr J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.09.022","article-title":"A gut microbial mimic that hijacks Diabetogenic autoreactivity to suppress colitis","volume":"171","author":"Hebbandi Nanjundappa","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb0765","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-3083.1990.tb02923.x","article-title":"Immunological tolerance to many self epitopes may be unnecessary","volume":"32","author":"Prehn","year":"1990","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2026.104192_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103303","article-title":"Antigen-specific T cells and autoimmunity","volume":"148","author":"Rojas","year":"2024","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.autrev.2026.104192_bb0775","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1039\/D4FO04430D","article-title":"The interaction between various food components and intestinal microbiota improves human health through the gut-X axis: independently or synergistically","volume":"16","author":"Li","year":"2025","journal-title":"Food Funct"},{"issue":"11","key":"10.1016\/j.autrev.2026.104192_bb0780","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41579-024-01068-4","article-title":"The interplay between diet and the gut microbiome: implications for health and disease","volume":"22","author":"Ross","year":"2024","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0785","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/acr2.11627","article-title":"Adherence to the Mediterranean diet in Italian patients with systemic sclerosis: an epidemiologic survey","volume":"6","author":"Natalello","year":"2024","journal-title":"ACR Open Rheumatol."},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0790","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2013.386","article-title":"Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI","volume":"109","author":"Murray","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104192_bb0795","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrgastro.2013.259","article-title":"Mechanisms and efficacy of dietary FODMAP restriction in IBS","volume":"11","author":"Staudacher","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104192_bb0800","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/ajcn\/nqab005","volume":"113","author":"Zhang","year":"2021","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.autrev.2026.104192_bb0805","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.gastro.2024.02.008","article-title":"Efficacy and findings of a blinded randomized reintroduction phase for the Low FODMAP diet in irritable bowel syndrome","volume":"167","author":"Van den Houte","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2026.104192_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2026.158466","article-title":"Indirect pharmacology of phytopolyphenols: the role of intermediate substances in cross-organ regulation and phenotypic outcomes","volume":"159","author":"Linh","year":"2026","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0815","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The international scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104192_bb0820","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The international scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0825","doi-asserted-by":"crossref","first-page":"1736974","DOI":"10.1080\/19490976.2020.1736974","article-title":"Probiotic-directed modulation of gut microbiota is basal microbiome dependent","volume":"12","author":"Hou","year":"2020","journal-title":"Gut Microbes."},{"key":"10.1016\/j.autrev.2026.104192_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108863","article-title":"Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability","volume":"98","author":"Liu","year":"2021","journal-title":"J Nutr Biochem"},{"issue":"10","key":"10.1016\/j.autrev.2026.104192_bb0835","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41575-019-0173-3","article-title":"Probiotics and prebiotics in intestinal health and disease: from biology to the clinic","volume":"16","author":"Sanders","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"16","key":"10.1016\/j.autrev.2026.104192_bb0840","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1039\/D5FO01925G","article-title":"Direct interaction between Lactiplantibacillus plantarum ZJ316-derived lipoteichoic acid and TLR2 mediates anti-inflammatory and barrier-protective effects in intestinal cells","volume":"16","author":"Han","year":"2025","journal-title":"Food Funct"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0845","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12916-024-03303-4","article-title":"Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials","volume":"22","author":"Zeng","year":"2024","journal-title":"BMC Med"},{"issue":"2 Suppl 65","key":"10.1016\/j.autrev.2026.104192_bb0850","first-page":"S22","article-title":"Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating\/ distention","volume":"29","author":"Frech","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2026.104192_bb0855","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/rheumatology\/kez160","article-title":"Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial","volume":"58","author":"Marighela","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2026.104192_bb0860","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s10620-019-05830-0","article-title":"Effectiveness of Saccharomyces boulardii and metronidazole for small intestinal bacterial overgrowth in systemic sclerosis","volume":"65","author":"Garc\u00eda-Collinot","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.autrev.2026.104192_bb0885","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232739","article-title":"Fecal microbiota transplantation in systemic sclerosis: a double-blind, placebo-controlled randomized pilot trial","volume":"15","author":"Fretheim","year":"2020","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0890","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/rheumatology\/kead014","article-title":"Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis","volume":"62","author":"Strahm","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2026.104192_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(24)00334-5","article-title":"Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"7","author":"Fretheim","year":"2025","journal-title":"Lancet Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104192_bb0900","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1572-0241.2007.01758.x","article-title":"Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication","volume":"103","author":"Parodi","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"6 Suppl 86","key":"10.1016\/j.autrev.2026.104192_bb0905","first-page":"S-82","article-title":"Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms","volume":"32","author":"Tauber","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0910","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5114\/ada.2020.101468","article-title":"Gut microbiome in systemic sclerosis: a potential therapeutic target","volume":"39","author":"Polkowska-Pruszy\u0144ska","year":"2022","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.autrev.2026.104192_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2025.128317","article-title":"Akkermansia muciniphila: a key player in gut microbiota-based disease modulation","volume":"301","author":"Shaheen","year":"2025","journal-title":"Microbiol Res"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0870","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41538-024-00339-x","article-title":"Akkermansia muciniphila ONE effectively ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis in mice","volume":"8","author":"Zhang","year":"2024","journal-title":"NPJ Sci Food"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb0875","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41564-025-01933-9","article-title":"ILC3s regulate the gut microbiota via host intestinal galactosylation to limit pathogen infection in mice","volume":"10","author":"Wang","year":"2025","journal-title":"Nat Microbiol"},{"issue":"567","key":"10.1016\/j.autrev.2026.104192_bb0880","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay6218","article-title":"Dietary simple sugars alter microbial ecology in the gut and promote colitis in mice","volume":"12","author":"Khan","year":"2020","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0915","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the international scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0920","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2019.1613124","article-title":"Potential for enriching next-generation health-promoting gut bacteria through prebiotics and other dietary components","volume":"11","author":"Lordan","year":"2020","journal-title":"Gut Microbes."},{"key":"10.1016\/j.autrev.2026.104192_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2021.110189","article-title":"Role of dietary polyphenols on gut microbiota, their metabolites and health benefits","volume":"142","author":"Mithul Aravind","year":"2021","journal-title":"Food Res Int"},{"key":"10.1016\/j.autrev.2026.104192_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2024.142391","article-title":"Polyphenols-rich Portulaca oleracea L. (purslane) alleviates ulcerative colitis through restiring the intestinal barrier, gut microbiota and metabolites","volume":"468","author":"Li","year":"2025","journal-title":"Food Chem"},{"issue":"6","key":"10.1016\/j.autrev.2026.104192_bb0935","article-title":"Postbiotics as multifunctional bioactives: mechanistic insights and translational applications in host physiology and microbial ecosystem modulation","volume":"14","author":"Sasidharan N","year":"2026","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb0940","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11274-025-04483-8","article-title":"Postbiotics: an insightful review of the latest category in functional biotics","volume":"41","author":"Amobonye","year":"2025","journal-title":"World J Microbiol Biotechnol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb0945","article-title":"Prebiotics for induction and maintenance of remission in ulcerative colitis","volume":"3","author":"Sinopoulou","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2026.104192_bb0950","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.neubiorev.2020.07.036","article-title":"Prebiotics, probiotics, fermented foods and cognitive outcomes: a meta-analysis of randomized controlled trials","volume":"118","author":"Marx","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0955","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ajcn\/nqz042","article-title":"Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"110","author":"Sharpton","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.autrev.2026.104192_bb0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103038","article-title":"Fecal microbiota transplantation: emerging applications in autoimmune diseases","volume":"141","author":"Yang","year":"2023","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.autrev.2026.104192_bb0965","article-title":"Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile)","volume":"4","author":"Minkoff","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2026.104192_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103058","article-title":"Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: what we learnt from the explorative clinical trial","volume":"141","author":"Xin","year":"2023","journal-title":"J Autoimmun"},{"issue":"7\u20138","key":"10.1016\/j.autrev.2026.104192_bb0975","article-title":"Fecal microbiota transplantation in autoimmune diseases - an extensive paper on a pathogenetic therapy","volume":"23","author":"Seida","year":"2024","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2026.104192_bb0980","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.chom.2023.03.020","article-title":"Key determinants of success in fecal microbiota transplantation: from microbiome to clinic","volume":"31","author":"Porcari","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"21","key":"10.1016\/j.autrev.2026.104192_bb0985","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-Resistant E. Coli bacteremia transmitted by fecal microbiota transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"N Engl J Med"},{"issue":"477","key":"10.1016\/j.autrev.2026.104192_bb0990","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw1815","article-title":"Transforming medicine with the microbiome","volume":"11","author":"Zmora","year":"2019","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb0995","doi-asserted-by":"crossref","DOI":"10.1186\/s13099-026-00795-8","article-title":"Broad-spectrum antibiotic treatment reshapes the gut microbiome, resistome, and colonization potential of opportunistic pathogens: a metagenomics study","volume":"18","author":"Tigabu","year":"2026","journal-title":"Gut Pathog"},{"issue":"10","key":"10.1016\/j.autrev.2026.104192_bb1000","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400356","article-title":"Rifaximin and alternative agents in the management of irritable bowel syndrome: a comprehensive review","volume":"357","author":"Deljavan Ghodrati","year":"2024","journal-title":"Arch Pharm (Weinheim)"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2026.104192_bb1005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/apt.13406","article-title":"Introduction: understanding mechanisms of the actions of rifaximin in selected gastrointestinal diseases","volume":"43","author":"DuPont","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb1010","first-page":"54","article-title":"Treatment of small intestinal bacterial overgrowth in Chilean patients with irritable bowel syndrome: a prospective and comparative study","volume":"90","author":"von Muhlenbrock","year":"2025","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb1015","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.autrev.2026.104192_bb1020","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7100413","article-title":"Detection of increased relative expression units of Bacteroides and Prevotella, and decreased Clostridium leptum in stool samples from Brazilian rheumatoid arthritis patients: a pilot study","volume":"7","author":"Rodrigues","year":"2019","journal-title":"Microorganisms"},{"issue":"10","key":"10.1016\/j.autrev.2026.104192_bb1025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19102938","article-title":"Analysis of gut microbiota in rheumatoid arthritis patients: disease-related Dysbiosis and modifications induced by Etanercept","volume":"19","author":"Picchianti-Diamanti","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb1030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13073-016-0299-7","article-title":"An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis","volume":"8","author":"Chen","year":"2016","journal-title":"Genome Med"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.12.008","article-title":"Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation","volume":"29","author":"Nayak","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.autrev.2026.104192_bb1040","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01894-24","article-title":"The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximab","volume":"13","author":"Ventin-Holmberg","year":"2025","journal-title":"Microbiol Spectr."},{"issue":"7","key":"10.1016\/j.autrev.2026.104192_bb1045","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/ueg2.70064","article-title":"Gut microbial signatures associated with clinical remission in inflammatory bowel disease treated with biologics: a comprehensive multi-cohort analysis","volume":"13","author":"Zheng","year":"2025","journal-title":"United European Gastroenterol J"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb1050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-022-01027-6","article-title":"Berberine treats atherosclerosis via a vitamine-like effect down-regulating choline-TMA-TMAO production pathway in gut microbiota","volume":"7","author":"Ma","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb1055","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-026-08869-w","article-title":"Probiotic interventions maintain intestinal barrier function and alleviate necrotizing enterocolitis by inhibiting ferroptosis in intestinal PMN-MDSCs","volume":"17","author":"Chen","year":"2026","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.autrev.2026.104192_bb1060","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1007\/s12602-025-10847-1","article-title":"Bifidobacterium animalis subsp. lactis GOLDGUT-BB69 counteracts diarrhea in mice by alleviating inflammation, enhancing intestinal barrier functions, and regulating intestinal microbiota","volume":"18","author":"Zhao","year":"2026","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb1065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12865-025-00700-z","article-title":"Using gut microbiota and non-targeted metabolomics techniques to study the effect of xylitol on alleviating DSS-induced inflammatory bowel disease in mice","volume":"26","author":"Ma","year":"2025","journal-title":"BMC Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104192_bb1070","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00383-019-04586-y","article-title":"Protective effects of vitamin D against injury in intestinal epithelium","volume":"35","author":"Lee","year":"2019","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.autrev.2026.104192_bb1075","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9782994","article-title":"Role of vitamin D in systemic sclerosis: a systematic literature review","volume":"2021","author":"Diaconu","year":"2021","journal-title":"J Immunol Res"},{"issue":"6","key":"10.1016\/j.autrev.2026.104192_bb1080","doi-asserted-by":"crossref","first-page":"G983","DOI":"10.1152\/ajpgi.00386.2020","article-title":"Larazotide acetate: a pharmacological peptide approach to tight junction regulation","volume":"320","author":"Slifer","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104192_bb1085","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41584-024-01217-2","article-title":"An international perspective on the future of systemic sclerosis research","volume":"21","author":"Abraham","year":"2025","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104192_bb1090","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.gastro.2020.09.057","article-title":"The healthy microbiome-what is the definition of a healthy gut microbiome?","volume":"160","author":"Shanahan","year":"2021","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1016\/j.autrev.2026.104192_bb1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.09.019","article-title":"A core microbiome signature as an indicator of health","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.autrev.2026.104192_bb1100","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41587-022-01628-0","article-title":"Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine","volume":"41","author":"Heinken","year":"2023","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104192_bb1105","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2096995","article-title":"Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases","volume":"14","author":"Mahmud","year":"2022","journal-title":"Gut Microbes."}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226002065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226002065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:45:52Z","timestamp":1791492352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226002065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":220,"alternative-id":["S1568997226002065"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104192","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota and systemic sclerosis: Mechanistic insights and microbial therapies","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104192"}}